In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
Keytruda is showing benefit to some patients with sarcoma, according to interim results from a phase 2 trial. According to interim results from the phase 2 SARC-028 trial, Keytruda (pembrolizumab) ...
In soft tissue sarcomas, the diagnosis of malignant fibrous histiocytoma (MFH) has been a very controversial issue, and MFH is now considered to be reclassified into pleomorphic subtypes of other ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 56-year-old man presented to the ED with 3 months of ...
A 70-year-old man was referred to an oncology clinic for a consultation due to a suspicion of a left kidney tumor. He occasionally experienced back pain that he attributed to having fallen off a ...
Please provide your email address to receive an email when new articles are posted on . A phase 2 trial conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results